NCT00775749View on ClinicalTrials.gov

Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV)

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2009

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

transdermal nicotine patch

The 7 mg transdermal nicotine patch will be applied to the right upper back prior to surgery. It will be covered with an opaque bandage to minimize inadvertent removal and conceal which patch has been placed.

DRUG

placebo patch

The placebo patch will be applied to the right upper back prior to surgery. It will be covered with an opaque bandage to minimize inadvertent removal and conceal which patch has been placed.

Trial Locations (1)

70121

Ochsner Clinic Foundation, New Orleans

Sponsors
All Listed Sponsors
lead

Ochsner Health System

OTHER

NCT00775749 - Transdermal Nicotine in Female Patients at High Risk for Post Operative Nausea and/or Vomiting (PONV) | Biotech Hunter | Biotech Hunter